483
Changzhou Sunlight Pharmaceutical Co., Ltd.FDA 483 - Changzhou Sunlight Pharmaceutical Co., Ltd. - May 31, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Changzhou Sunlight Pharmaceutical Co., Ltd., an API manufacturer, was inspected by the FDA. The inspection revealed a significant issue where equipment used in the manufacturing of API intermediates was not operating within its appropriate range. This included discrepancies between set and actual parameters and the use of recording instruments with incorrect ranges, indicating potential quality control failures.
Open in Dashboard
ID · 2031673a-3c88-4e41-b326-8113d7c4db60